title: Non-Hodgkin's lymphoma associated with human immunodeficiency virus: treatment with LNH 84 regimen in a selected group of patients.
authors.affiliation: Institut d'Hématologie, Hôpital Saint Louis, Paris, France.
authors.forename: C
authors.initials: C
authors.lastname: Gisselbrecht
authors.forename: E
authors.initials: E
authors.lastname: Oksenjendler
authors.forename: U
authors.initials: U
authors.lastname: Tirelli
authors.forename: J
authors.initials: J
authors.lastname: Gabarre
authors.forename: R
authors.initials: R
authors.lastname: Gastaldi
authors.forename: J P
authors.initials: JP
authors.lastname: Farcet
authors.forename: A
authors.initials: A
authors.lastname: Thyss
authors.forename: B
authors.initials: B
authors.lastname: Coiffier
authors.forename: M
authors.initials: M
authors.lastname: Raphael
authors.forename: E
authors.initials: E
authors.lastname: Lepage
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D016483:Lymphoma, AIDS-Related / Q000188:drug therapy* / Q000401:mortality; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy* / Q000401:mortality; D010865:Pilot Projects; D011239:Prednisolone / Q000008:administration & dosage; D011379:Prognosis; D012074:Remission Induction; D014751:Vindesine / Q000008:administration & dosage
chemical_list: D001761:Bleomycin; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone; D014751:Vindesine